In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.
Regulation of Platelet Activation and Coagulation: Current Concepts, Novel Targets, and Therapies Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions Antithrombotic Therapy in Patients with Chronic Coronary Syndromes Antithrombotic Therapy in Acute Coronary Syndrome Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.
Delivery policy
Security policy
Return policy
